Pharmacogenetics - Trends
Research News and Information

Monday, November 23, 2009

Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.

4 Jul 2009 Cancer pharmacogenetics is a popular and evolving field in medicine with applications in various types of tumours helping clinicians to apply a more personalized medicine by providing information of prognostic, predictive and therapeutic value. Such ... Read more...

Addressing the challenges of the clinical application of pharmacogenetic testing.

29 Jun 2009 Pharmacogenomics aims to use molecular genetic markers to predict treatment outcome. Indeed, within the past decade there has been a rapid emergence of pharmacogenetic tests to aid clinicians in predicting efficacy or toxicity for some drugs. ... Read more...

Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics.

29 Apr 2009 Novel multistranded and alternative DNA, RNA and plasmid microarrays (transitional structural nucleic acid microarrays) have been developed that allows for the immobilization of intact, nondenatured, double-stranded DNA, double-stranded RNA, and ... Read more...

Latest indexed articles for 'Pharmacogenetics - Trends'

These are the very latest articles for this heading:

• Cardiovascular disease gets personal. 18 Aug 2009
• Foreword. Drug allergy and primum non-nocere. 30 Jul 2009
• Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009. 4 Jul 2009
• Addressing the challenges of the clinical application of pharmacogenetic testing. 29 Jun 2009
• Personalized therapy and pharmacogenomics: future perspective. 30 May 2009
• Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics. 29 Apr 2009
• United Europeans for development of pharmacogenomics in multiple sclerosis network. 29 Apr 2009
• Systematic screening for polymorphisms within the UGT1A6 gene in three Chinese populations and function prediction through structural modeling. 29 Apr 2009
• Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment. 27 Apr 2009
• Clinically available pharmacogenomics tests. 13 Apr 2009
• Perspective on the application of pharmacogenomics in the treatment of cancer. 30 Mar 2009
• Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications. 30 Mar 2009
• Pharmacogenomics: has our history become modern medicine? 30 Mar 2009
• Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy. 30 Mar 2009
• Pharmacogenetics: from discovery to patient care. 30 Mar 2009
• Genomic discoveries in perioperative medicine: educating the audience. 30 Mar 2009
• Pharmacogenetics of pharmacoecology: which route to personalized medicine? 30 Mar 2009
• Pharmacogenetics in hemostasis: friend or foe? 21 Mar 2009
• Laboratory diagnostics and therapy in thrombosis and hemostasis: from bedside to bench to bedside. 21 Mar 2009
• The microeconomics of personalized medicine: today's challenge and tomorrow's promise. 18 Mar 2009

See a longer list of these articles.

Technical information about 'Pharmacogenetics'

Definition: A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).

Descriptor UI: D010597

Alternative terms: Pharmacogenetics; Pharmacogenomics;

Related Mesh Headings: Drug Resistance; Toxicology;

Allowable Qualifiers: classification; economics; education; history; instrumentation; legislation & jurisprudence; manpower; methods; organization & administration; standards; trends; statistics & numerical data; ethics;

Tree Number: H01.158.273.343.750; H01.158.703.052; H02.628.479;

History Note: 70(66)

Technical Notes: SPEC or GEN; prefer specific drug & specific genetic aspect: Manual 28.22.5